BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11250770)

  • 21. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-alpha and autoimmune thyroid disease.
    Prummel MF; Laurberg P
    Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
    Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
    Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
    Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
    Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
    Nadeem A; Aslam M; Khan DA; Hussain T; Khan SA
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):86-9. PubMed ID: 19208310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.
    Fabbri C; Jaboli MF; Giovanelli S; Azzaroli F; Pezzoli A; Accogli E; Liva S; Nigro G; Miracolo A; Festi D; Colecchia A; Montagnani M; Roda E; Mazzella G
    World J Gastroenterol; 2003 Jul; 9(7):1487-90. PubMed ID: 12854147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
    Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
    Kozielewicz D; Halota W
    Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
    Kee KM; Lee CM; Wang JH; Tung HD; Changchien CS; Lu SN; Wang PW
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):319-26. PubMed ID: 16460494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.
    Dalgard O; Bjøro K; Hellum K; Myrvang B; Bjøro T; Haug E; Bell H
    J Intern Med; 2002 May; 251(5):400-6. PubMed ID: 11982739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
    Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
    Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?
    Mazziotti G; Sorvillo F; Carbone A; Cioffi M; Morisco F; Carella C
    J Intern Med; 2002 Oct; 252(4):377-8; author reply 379. PubMed ID: 12366611
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV-HIV co-infected patients before and after interferon alpha therapy: A prospective study.
    Lowenstein A; Fainboim H; Reyes A; Lutzky C; Ameigeiras B; Schroder T; Eugenio Russmann ML
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Apr; 67(4):263-271. PubMed ID: 31266712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.